Study on the mechanism of mitochondrial dysfunction and CPT1A/ERK signal transduction pathway regulating malignant behavior in breast cancer

doi:10.19401/j.cnki.1007-3639.2024.07.004

Abstract

Abstract:

Background and purpose: The overexpression of carnitine palmitoyl transferase 1A (CPT1A) is related to the poor prognosis of breast cancer, and it can promote the utilization of fatty acids by mitochondria and maximize triphosphate (ATP) production. However, the role of CPT1A in breast cancer metastasis is still unclear. This study aimed to explore the mechanism that mitochondrial dysfunction and CPT1A/extracellular signal-regulated kinase (ERK) signaling pathway in breast cancer jointly regulate the malignant behavior of breast cancer. Methods: The lentivirus system and shRNA tools were used to overexpress or knock down CPT1A in human breast cancer cell lines MDA-MB-231 and MCF7, and the cells were divided into NC group, CPT1A group and shCPT1A group. The invasion ability of cells was detected by transwell assay, and the protein expressions of peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α), ERK1/2 and CPT1A were analyzed by Western blot. The mitochondrial morphology of MDA-MB-231 and MCF7 cell lines was analyzed using mitochondrial red staining, and mitochondrial respiratory capacity was analyzed by oxygen consumption rate. Results: Compared with cells expressing control vector, overexpression of CPT1A resulted in enhanced invasion abilities of MCF7 cells and MDA-MB-231 cells (P<0.05), while knockdown of shCPT1A resulted in decreased invasion abilities of cells (P<0.05). Compared with NC group, the length of mitochondrial branches in MDA-MB-231 and MCF7 cells in CPT1A group was significantly shorter (P<0.05), and the expressions of ERK1/2 and PGC-1α increased significantly (P <0.05). In shCPT1A group, the length of mitochondrial branches in MDA-MB-231 and MCF7 cells increased significantly (P <0.05), and the expressions of ERK1/2 and PGC-1α decreased significantly (P<0.05). In addition, compared with NC group, the cellular basis, maximum respiratory capacity and ATP production of MDA-MB-231 in CPT1A group increased significantly (P <0.05), while the cellular basis, maximum respiratory capacity and ATP production of MDA-MB-231 in shCPT1A group decreased significantly (P<0.05). Conclusion: ERK1/2-PGC-1α activated by CPT1A Signaling pathway plays a key role in mitochondrial division mediated breast cancer cell metastasis.

Key words: Breast cancer, Mitochondria, Carnitine palmitoyl transferase 1A, Extracellular signal-regulated kinase, Malignant behavior

CLC Number:

R737.9

JIANG Dan, SONG Guoqing, WANG Xiaodan. Study on the mechanism of mitochondrial dysfunction and CPT1A/ERK signal transduction pathway regulating malignant behavior in breast cancer[J]. China Oncology, 2024, 34(7): 650-658.

Figures/Tables 4

Fig. 1

Fig. 2

Fig. 3

Fig. 4

References 25

[1]	GIAQUINTO A N, SUNG H, MILLER K D, et al. Breast cancer statistics, 2022[J]. CA Cancer J Clin, 2022, 72(6): 524-541.
[2]	XIA C F, DONG X S, LI H, et al. Cancer statistics in China and United States, 2022: profiles, trends, and determinants[J]. Chin Med J, 2022, 135(5): 584-590.
[3]	GALIANDRO F, AGNES S, MOSCHETTA G, et al. Prognostic factors in patients with breast cancer liver metastases undergoing liver resection: systematic review and meta-analysis[J]. Cancers, 2022, 14(7): 1691.
[4]	KOTECHA R, TONSE R, RUBENS M, et al. Systematic review and meta-analysis of breast cancer brain metastasis and primary tumor receptor expression discordance[J]. Neurooncol Adv, 2021, 3(1): vdab010.
[5]	VONA R, MILEO A M, MATARRESE P. Microtubule-based mitochondrial dynamics as a valuable therapeutic target in cancer[J]. Cancers, 2021, 13(22): 5812.
[6]	KUMAR H, GUPTA N V, JAIN R, et al. A review of biological targets and therapeutic approaches in the management of triple-negative breast cancer[J]. J Adv Res, 2023, 54: 271-292.
[7]	JIANG N, XING B Z, PENG R, et al. Inhibition of Cpt1a alleviates oxidative stress-induced chondrocyte senescence via regulating mitochondrial dysfunction and activating mitophagy[J]. Mech Ageing Dev, 2022, 205: 111688.
[8]	SAVUKAITYTĖ A, BARTNYKAITĖ A, BEKAMPYTĖ J, et al. DDIT4 downregulation by siRNA approach increases the activity of proteins regulating fatty acid metabolism upon aspirin treatment in human breast cancer cells[J]. Curr Issues Mol Biol, 2023, 45(6): 4665-4674. doi: 10.3390/cimb45060296 pmid: 37367045
[9]	JOSHI M, KIM J, D’ALESSANDRO A, et al. CPT1A over-expression increases reactive oxygen species in the mitochondria and promotes antioxidant defenses in prostate cancer[J]. Cancers, 2020, 12(11): 3431.
[10]	DAS M, GIANNOUDIS A, SHARMA V. The role of CPT1A as a biomarker of breast cancer progression: a bioinformatic approach[J]. Sci Rep, 2022, 12(1): 16441. doi: 10.1038/s41598-022-20585-x pmid: 36180554
[11]	ZHANG W, DU X F, LIU B, et al. Engineering supramolecular nanomedicine for targeted near infrared-triggered mitochondrial dysfunction to potentiate cisplatin for efficient chemophototherapy[J]. ACS Nano, 2022, 16(1): 1421-1435.
[12]	FORTE M, SCHIRONE L, AMERI P, et al. The role of mitochondrial dynamics in cardiovascular diseases[J]. Br J Pharmacol, 2021, 178(10): 2060-2076.
[13]	YOU Y, MURAOKA S, JEDRYCHOWSKI M P, et al. Human neural cell type-specificextracellular vesicle proteome defines disease-related molecules associated with activated astrocytes in Alzheimer’s disease brain[J]. J Extracell Vesicles, 2022, 11(1): e12183.
[14]	ANSARI M I, BANO N, KAINAT K M, et al. Bisphenol A exposure induces metastatic aggression in low metastatic MCF-7 cells via PGC-1α mediated mitochondrial biogenesis and epithelial-mesenchymal plasticity[J]. Life Sci, 2022, 302: 120649.
[15]	MIDDLETON P, VERGIS N. Mitochondrial dysfunction and liver disease: role, relevance, and potential for therapeutic modulation[J]. Therap Adv Gastroenterol, 2021, 14: 17562848211031394.
[16]	LIU Y E, SHI Y F. Mitochondria as a target in cancer treatment[J]. MedComm, 2020, 1(2): 129-139. doi: 10.1002/mco2.16 pmid: 34766113
[17]	LEE K M, GILTNANE J M, BALKO J M, et al. MYC and MCL1 cooperatively promote chemotherapy-resistant breast cancer stem cells via regulation of mitochondrial oxidative phosphorylation[J]. Cell Metab, 2017, 26(4): 633-647. e7.
[18]	PRAHARAJ P P, PATRO B S, BHUTIA S K. Dysregulation of mitophagy and mitochondrial homeostasis in cancer stem cells: novel mechanism for anti-cancer stem cell-targeted cancer therapy[J]. Br J Pharmacol, 2022, 179(22): 5015-5035.
[19]	ZHANG L, SUN L, WANG L R, et al. Mitochondrial division inhibitor (mdivi-1) inhibits proliferation and epithelial-mesenchymal transition via the NF-κB pathway in thyroid cancer cells[J]. Toxicol In Vitro, 2023, 88: 105552.
[20]	RANA A, OLIVEIRA M P, KHAMOUI A V, et al. Promoting Drp1-mediated mitochondrial fission in midlife prolongs healthy lifespan of drosophila melanogaster[J]. Nat Commun, 2017, 8(1): 448. doi: 10.1038/s41467-017-00525-4 pmid: 28878259
[21]	HU N, CHEN X M, CHEN C C, et al. Exploring the role of esketamine in alleviating depressive symptoms in mice via the PGC-1α/irisin/ERK1/2 signaling pathway[J]. Sci Rep, 2023, 13(1): 16611.
[22]	HUANG K Y, LIU Z Y, XIE Z L, et al. HIGD2A silencing impairs hepatocellular carcinoma growth via inhibiting mitochondrial function and the MAPK/ERK pathway[J]. J Transl Med, 2023, 21(1): 253. doi: 10.1186/s12967-023-04105-7 pmid: 37041638
[23]	LIU J F, NING L. Protective role of emodin in rats with post-myocardial infarction heart failure and influence on extracellular signal-regulated kinase pathway[J]. Bioengineered, 2021, 12(2): 10246-10253. doi: 10.1080/21655979.2021.1983977 pmid: 34839778
[24]	LAURIN K M, COUTU-BEAUDRY K, SALAZAR A, et al. Low expression of PGC-1β and other mitochondrial biogenesis modulators in melanoma is associated with growth arrest and the induction of an immunosuppressive gene expression program dependent on MEK and IRF-1[J]. Cancer Lett, 2022, 541: 215738.
[25]	ASL E R, AMINI M, NAJAFI S, et al. Interplay between MAPK/ERK signaling pathway and microRNAs: a crucial mechanism regulating cancer cell metabolism and tumor progression[J]. Life Sci, 2021, 278: 119499.